Home Cart 0 Sign in  
X

[ CAS No. 20781-20-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 20781-20-8
Chemical Structure| 20781-20-8
Chemical Structure| 20781-20-8
Structure of 20781-20-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 20781-20-8 ]

Related Doc. of [ 20781-20-8 ]

Alternatived Products of [ 20781-20-8 ]

Product Details of [ 20781-20-8 ]

CAS No. :20781-20-8 MDL No. :MFCD00052393
Formula : C9H13NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :QOWBXWFYRXSBAS-UHFFFAOYSA-N
M.W : 167.21 Pubchem ID :597250
Synonyms :

Calculated chemistry of [ 20781-20-8 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 47.1
TPSA : 44.48 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.43 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.0
Log Po/w (XLOGP3) : 1.25
Log Po/w (WLOGP) : 1.01
Log Po/w (MLOGP) : 0.92
Log Po/w (SILICOS-IT) : 1.44
Consensus Log Po/w : 1.32

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.84
Solubility : 2.44 mg/ml ; 0.0146 mol/l
Class : Very soluble
Log S (Ali) : -1.78
Solubility : 2.76 mg/ml ; 0.0165 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.69
Solubility : 0.341 mg/ml ; 0.00204 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.28

Safety of [ 20781-20-8 ]

Signal Word:Danger Class:8
Precautionary Statements:P501-P264-P280-P303+P361+P353-P301+P330+P331-P363-P304+P340+P310-P305+P351+P338+P310-P405 UN#:2735
Hazard Statements:H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 20781-20-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 20781-20-8 ]
  • Downstream synthetic route of [ 20781-20-8 ]

[ 20781-20-8 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 31874-34-7 ]
  • [ 20781-20-8 ]
Reference: [1] Synthetic Communications, 1995, vol. 25, # 6, p. 863 - 869
[2] Tetrahedron, 2005, vol. 61, # 34, p. 8130 - 8137
[3] Journal of Organic Chemistry, 1971, vol. 36, p. 3966 - 3970
[4] European Journal of Medicinal Chemistry, 2017, vol. 135, p. 24 - 33
  • 2
  • [ 613-45-6 ]
  • [ 20781-20-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 21, p. 6197 - 6208
[2] Tetrahedron, 2005, vol. 61, # 34, p. 8130 - 8137
[3] European Journal of Medicinal Chemistry, 2017, vol. 135, p. 24 - 33
  • 3
  • [ 20781-21-9 ]
  • [ 20781-20-8 ]
Reference: [1] Patent: WO2004/113275, 2004, A2, . Location in patent: Page 174
  • 4
  • [ 4107-65-7 ]
  • [ 20781-20-8 ]
  • [ 20781-23-1 ]
Reference: [1] Synthetic Communications, 2002, vol. 32, # 8, p. 1265 - 1269
  • 5
  • [ 4107-65-7 ]
  • [ 20781-20-8 ]
Reference: [1] Chemische Berichte, 1968, vol. 101, # 10, p. 3623 - 3641
  • 6
  • [ 20781-20-8 ]
  • [ 613-45-6 ]
  • [ 20781-23-1 ]
YieldReaction ConditionsOperation in experiment
99% With sodium tris(acetoxy)borohydride In tetrahydrofuran at 20℃; 2,4-dimethoxybenzaidehyde (Sigma Aldrich; 1.1 g, 661 mmoi) wasdissolved in 20 rnL THF at ambient temperature. To the solution was added 2,4- dimethoxybenzyiamine (Sigma Aldrich; 1.5 rnL, 9.98 mrnol) followed by sodium triacetoxyborohydride (Sigma Aldrich; 1 7 g; 8.4 inmol) and the mixture(increasingly cloudy) was stirred at ambient temperature overnight. The mixturewas then diluted with sat. NaHCO3 and extracted with EtOAc, dried over MgSO4and concentrated. The residue was purified by chromatography on 40 g ISCOcolumn eluting with a gradient of 0 to 100percent EtOAc to deliver bis(2,4-dimethoxybenzyi)amine (2.08 g, 6.55 mrnol, 99percent yield, 96percent purity)
8 g
Stage #1: at 20℃; for 2 h;
Stage #2: With sodium tris(acetoxy)borohydride In ethanol at 20℃; for 1 h;
A)
bis(2,4-dimethoxybenzyl)amine
A solution of 2,4-dimethoxybenzylamine (8.98 mL) and 2,4-dimethoxybenzaldehyde (9.94 g) in ethanol (200 mL) was stirred at room temperature for 2 hr.
To the reaction mixture was added sodium triacetoxyborohydride (20.3 g), and the mixture was stirred at room temperature for 1 hr.
To the reaction mixture was added water, the solvent was evaporated under reduced pressure, and the residue was purified by silica gel column chromatography (ethyl acetate/hexane) to give the title compound (8 g).
1H NMR (300 MHz, DMSO-d6) δ2.01 (1H, brs) 3.55 (4H, s) 3.74 (6H, s) 3.75 (6H, s) 6.46 (2H, dd, J=8.1, 2.3 Hz) 6.51 (2H, d, J=2.3 Hz) 7.18 (2H, d, J=8.1 Hz).
Reference: [1] Patent: WO2017/147410, 2017, A1, . Location in patent: Page/Page column 1832
[2] Tetrahedron Letters, 2010, vol. 51, # 28, p. 3645 - 3648
[3] Chemische Berichte, 1968, vol. 101, # 10, p. 3623 - 3641
[4] Patent: US2013/131050, 2013, A1, . Location in patent: Paragraph 0570; 0571
[5] Patent: WO2018/97945, 2018, A1, . Location in patent: Paragraph 0395
  • 7
  • [ 4107-65-7 ]
  • [ 20781-20-8 ]
  • [ 20781-23-1 ]
Reference: [1] Synthetic Communications, 2002, vol. 32, # 8, p. 1265 - 1269
  • 8
  • [ 20781-20-8 ]
  • [ 20781-23-1 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 37, p. 7610 - 7617
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 20781-20-8 ]

Aryls

Chemical Structure| 6851-80-5

[ 6851-80-5 ]

1-(2-Methoxyphenyl)-N-methylmethanamine

Similarity: 0.91

Chemical Structure| 34967-24-3

[ 34967-24-3 ]

3,5-Dimethoxybenzyl amine

Similarity: 0.90

Chemical Structure| 2393-23-9

[ 2393-23-9 ]

4-Methoxybenzylamine

Similarity: 0.90

Chemical Structure| 5071-96-5

[ 5071-96-5 ]

3-Methoxybenzylamine

Similarity: 0.90

Chemical Structure| 83304-59-0

[ 83304-59-0 ]

N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine hydrochloride

Similarity: 0.89

Ethers

Chemical Structure| 6851-80-5

[ 6851-80-5 ]

1-(2-Methoxyphenyl)-N-methylmethanamine

Similarity: 0.91

Chemical Structure| 34967-24-3

[ 34967-24-3 ]

3,5-Dimethoxybenzyl amine

Similarity: 0.90

Chemical Structure| 2393-23-9

[ 2393-23-9 ]

4-Methoxybenzylamine

Similarity: 0.90

Chemical Structure| 5071-96-5

[ 5071-96-5 ]

3-Methoxybenzylamine

Similarity: 0.90

Chemical Structure| 83304-59-0

[ 83304-59-0 ]

N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine hydrochloride

Similarity: 0.89

Amines

Chemical Structure| 6851-80-5

[ 6851-80-5 ]

1-(2-Methoxyphenyl)-N-methylmethanamine

Similarity: 0.91

Chemical Structure| 34967-24-3

[ 34967-24-3 ]

3,5-Dimethoxybenzyl amine

Similarity: 0.90

Chemical Structure| 2393-23-9

[ 2393-23-9 ]

4-Methoxybenzylamine

Similarity: 0.90

Chemical Structure| 5071-96-5

[ 5071-96-5 ]

3-Methoxybenzylamine

Similarity: 0.90

Chemical Structure| 83304-59-0

[ 83304-59-0 ]

N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine hydrochloride

Similarity: 0.89